InvestorsHub Logo
icon url

genisi

11/01/10 1:28 PM

#107686 RE: DewDiligence #107681

Telaprevir is clearly superior. Who will use Boceprevir? I suppose those who could not tolerate or failed telaprevir. Can't be a big market.